| 查看: 1671 | 回复: 7 | |||
| 【有奖交流】积极回复本帖子,参与交流,就有机会分得作者 vnyh3993 的 4 个金币 ,回帖就立即获得 1 个金币,每人有 1 次机会 | |||
[交流]
IgY-Technology英文专著在Springer出版
|
|||
|
IgY-Technology: Production and Application of Egg Yolk Antibodies: Basic Knowledge for a Successful Practice, Springer Nature Group, Switzerland 近日,IgY抗体技术专著(IgY-Technology: Production and Application of Egg Yolk Antibodies: Basic Knowledge for a Successful Practice, Springer Nature Group, Switzerland. 2021. ISBN: 978-3-030-72686-7. https://www.springer.com/gp/book/9783030726867#aboutBook)在Springer出版社出版,该书是全球范围内第一部针对IgY抗体技术的系统性英文学术专著,由张小莺教授领衔主编,联合近二十个国家的四十多位学者历时多年编撰而成。 专著链接:https://www.springer.com/gp/book/9783030726867 该专著共18章,系统性的回顾和总结了IgY抗体技术的发展历程、技术特点和发展前沿,涉及理论基础、技术方法学及生物医药领域的研发应用。专著覆盖了IgY技术相关的各个领域,如进化视野下的IgY分子机制、受体与转运机制、免疫技术、IgY抗体的不同提取纯化策略、储存稳定性、工业化生产、在人类和兽医领域中的应用、IgY递送策略、IgY基因工程抗体制备、转基因动物开发、IgY产品报批及产业化,技术局限与创新等。 近年来,IgY抗体技术(卵黄抗体技术)不断发展,具备了相对完备统一的技术模式;不断与现代生物学技术相结合,拓展技术自生的内涵和外延;相关产品在世界范围内不断报批问世,形成了一定的产业基础。 据悉,科学出版社将与张小莺教授团队合作,在2011年中文版的基础上,适时推出IgY抗体技术中文第二版,以供中国读者和研究人员参考、交流。 图书信息 This first edited Volume on IgY-Technology, addresses the historical and dynamic development of IgY-applications. The authors cover the biological basis and theoretical context, methodological guidance, and applications of IgY-Technology. A focus is laid on the use of IgY-antibodies for prophylactic/therapeutic purposes in human and veterinary medicine. Aside from applications, the chapters also offer an evolutionary understanding of the IgY molecule, IgY receptors and practical prerequisites to produce IgY-antibodies. Guidance is given for every step of the process. Starting with an introduction to hens as a model species and including hen husbandry, hen egg-laying capacity and total IgY outcomes. Readers will also learn about immunization techniques, the advantages and limitations of different IgY extraction methods, as well as storage stability of the final product. The last part of the volume highlights hands-on aspects of applications, such as IgY delivery strategies, new methods to produce monoclonal IgY-antibodies or production of functional IgY fragments by phage-display as well as commercial exploitation of the technology. Thus, this book is a valuable resource and guide for Scientists, Clinicians and Health Product Developers in both human and veterinary medicine. 主编信息 Prof. Dr. Xiaoying ZHANG, PhD in Pharmacology (Charité Medical University Berlin), Distinguished Professor at Shaanxi Univ. of Technology (2019-present); Senior Researcher at CBMA, Univ. of Minho, Portugal (2016-present); Professor (Adjunct) at Univ. of Guelph, Canada (2017-present); Professor at Northwest Agricultural & Forestry Univ., China (2008-2018). He has been dedicated to the development, popularisation and application of IgY Technology. Ricardo S. Vieira-Pires is an Assistant Investigator at the Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Portugal. He obtained his PhD in Structural Biology (2008) at University Joseph Fourier, Grenoble, France. He is head of the Structural Biotechnology Group that studies proteins and molecular assemblies involved in key processes of bacterial and viral infectious diseases. He is particularly interested in targeting microbial surface-exposed virulent factors using antibodies. He is head of the CNC – Avian Technological Unit that explores bird immune repertoires for antibody discovery. He is engaged with academic and industry partners promoting IgY Technology-based solutions for human and veterinary medicine. Patricia M. Morgan is an Emerita Senior Lecturer at the National University of Ireland Galway (NUI Galway). Having been awarded a PhD in Biochemistry at NUI Galway, she undertook post-doctoral research at the University of Wisconsin-Madison, USA in the areas of reproductive biology and endocrinology. She has held senior positions at NUI Galway as Dean of the College of Science and Dean of Graduate Studies. In these posts, she has championed research developments within the University particularly in the areas of Biotechnology and Innovation. She has served on various national committees promoting science and is an advocate for the public understanding of science and the promotion of inclusion and diversity in academia. Rüdiger Schade started his scientific career at the Institute of Pharmacology, Charité – Universitätsmedizin in Berlin, Germany, in 1976. Since the early 1990’s, his research has been strongly focused on the development, production and application of IgY antibodies. His contributions significantly influenced the field of IgY-technology and promoted the application of this technology worldwide, particularly in Latin-America. In acknowledgement of his research efforts, he received the FISEA prize – the International Foundation for the Substitution of Animal Experimentation, Luxemburg - in 1997. |
» 猜你喜欢
327求调剂
已经有7人回复
26考研一志愿中国石油大学(华东)305分求调剂
已经有3人回复
伙伴们,祝我生日快乐吧
已经有23人回复
NSFC申报书里申请人简历中代表性论著还需要在申报书最后的附件里面再上传一遍吗
已经有13人回复
0856专硕279求调剂
已经有5人回复
本人考085602 化学工程 专硕
已经有7人回复
22408总分284求调剂
已经有3人回复
070305求调剂
已经有4人回复
材料专硕326求调剂
已经有4人回复
294求调剂
已经有4人回复
» 本主题相关商家推荐: (我也要在这里推广)
» 抢金币啦!回帖就可以得到:
崂山国家实验室博士后岗位招聘
+2/224
招收调剂生,动物医学、水产养殖、水产动物医学等专业
+1/84
哈工大本部-电化学新能源方向博士捡漏名额
+1/78
福建师范大学招收2026年化学、材料硕士3-4名
+1/78
加拿大阿尔伯塔大学招收电磁、无线通信、机器学习方向全奖硕士/博士/博士后/访问学者
+1/59
华南师范大学(211)博士招生- 电子、自动化、机械、生物学、物理相关专业
+2/58
何时使用 CODA™ 科里奥利质量流量仪表- 艾里卡特(Alicat)
+2/54
0854电子信息调剂,集成电路,芯片方向,闽南师范大学光电芯片研发实验室
+1/35
结节穿刺等待中,求良性
+1/34
西安建筑科技大学,樊重庆课题组招收调剂研究生1名。
+2/28
国家级领军人才团队高分子材料方向2026年博士研究生招生
+1/16
医学327分专硕调剂
+1/16
中国科学院苏州纳米所院士团队博士后岗位招聘
+1/15
福建师范大学化学与材料学院杜克钊团队博士/硕士招生
+1/15
青岛科技大学可持续高分子团队 考研招生
+1/9
连发两篇 Nature!大样本单细胞测序解析认知、衰老与灵长类进化
+1/4
095400 森林培育 303求调剂
+1/2
杭州北航国新院徐梁教授招聘博士(控制/机器视觉/机器人导航操作方向)
+1/2
中科院天津工业生物技术所与哈尔滨工业大学联合博士招生2026
+1/1
材料294求调剂
+1/1
zzd0414112
禁虫 (正式写手)
★
vnyh3993(金币+1): 谢谢参与
vnyh3993(金币+1): 谢谢参与
|
本帖内容被屏蔽 |
4楼2021-03-15 20:35:45
简单回复
tzynew2楼
2021-03-10 15:51
回复
vnyh3993(金币+1): 谢谢参与
o 发自小木虫Android客户端
Alexpep3楼
2021-03-12 22:03
回复
vnyh3993(金币+1): 谢谢参与
2021-03-15 20:36
回复


2021-03-17 07:58
回复
vnyh3993(金币+1): 谢谢参与
7
2021-03-17 13:18
回复
vnyh3993(金币+1): 谢谢参与
nono20098楼
2021-08-26 20:15
回复
vnyh3993(金币+1): 谢谢参与
·













回复此楼
